Results 211 to 220 of about 158,411 (308)

Anticoagulation Therapy for Atrial Fibrillation After Transcatheter Aortic Valve Replacement: National Database Insights. [PDF]

J Am Heart Assoc
Takegawa K, Kanaoka K, Iwanaga Y, Sasano T, Nishioka Y, Myojin T, Noda T, Imamura T, Miyamoto Y.   +8 more
europepmc   +1 more source

Evaluation of a Rat Cardiopulmonary Bypass Model Using an Extraluminal Flow Oxygenator

Artificial Organs, EarlyView.
A rat cardiopulmonary bypass model was constructed incorporating the developed extraluminal flow oxygenator and compared with a commercial intraluminal flow oxygenator. Both oxygenators demonstrated comparable gas exchange performance and inflammatory responses; however, the one developed in this study better preserved PLT counts.
Hirohito Sumikura, Yutaka Fujii, Shunsuke Uchiyama, Akihiko Homma   +3 more
wiley   +1 more source

Oral Anticoagulation Therapy: An Update on Usage and Costs in the Endemic COVID-19 Era. [PDF]

J Clin Med
Favaloro EJ, Pasalic L, Lippi G.
europepmc   +1 more source

Predictors of Brain Infarction in Pediatric Patients During Extracorporeal Membrane Oxygenation

Artificial Organs, EarlyView.
In 179 pediatric ECMO patients, brain infarction (BI) occurred in 28% and was linked to markedly higher 30‐day mortality. VA ECMO mode (vs. VV) and higher pre‐ECMO arterial lactate independently predicted BI, supporting standardized neuro‐monitoring and liberal early brain CT, especially for children on VA ECMO.
Riccardo Iacobelli, Thomas Fux, Sara Wood Schalling, Sarah Kopfer, Jonas Berner, Alexander Fletcher‐Sandersjöö, Lars Mikael Broman   +6 more
wiley   +1 more source

Anticoagulation Therapy and Severe Traumatic Brain Injury: A Retrospective Cohort Study on Clinical Outcomes Using TriNetX. [PDF]

J Clin Med
Rasmussen S, Shaik K, Rawson C, Saloum A, Rahme R, Karsy M.   +5 more
europepmc   +1 more source

Standardization of In Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development

Artificial Organs, EarlyView.
ABSTRACT Extracorporeal life support (ECLS) technology has witnessed remarkable advancements during the last decades. However, further research and development of devices are required to increase, for example, performance‐efficiency, hemocompatibility, and long‐term stability.
Jutta Arens, Mirko Belliato, Lars Mikael Broman, Johanna C. Clauser, Dirk W. Donker, Roberto Lorusso, Maximilian Malfertheiner, Sasa Rajsic, Justyna Swol, Leen Vercaemst, Lisa Prahl Wittberg, on behalf of the EACTS Innovation Committee, Section CPB, ECLS & MCS, the EuroELSO Innovation Group, Jutta Arens, Mirko Belliato, Lars Mikael Broman, Johanna C. Clauser, Matteo Di Nardo, Dirk Donker, Lorenzo Grazioli, Johannes Heinze, Roberto Lorusso, Maximilian Malfertheiner, Matthias Menne, Sasa Rajsic, Lena Schlotterhose, Niklas Steuer, Justyna Swol, Leen Vercaemst, Jutta Arens. Section Members, Lars Mikael Broman, Johanna C. Clauser, Renard Haumann, Michael Hübler, David Kalfa, Timur Lesbekov, Lisa Prahl Wittberg, Thomas Schlöglhofer, Zuzana Tucanova, André Vincentelli   +41 more
wiley   +1 more source

Effectiveness and safety of bivalirudin anticoagulation therapy in adult patients receiving extracorporeal membrane oxygenation: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Hu Y, Yu L, Yang W.
europepmc   +1 more source

An In Vitro System for Studying Toxin Transport Across Hemodialysis Membranes

Artificial Organs, EarlyView.
Development of an in vitro hemodialysis (HD) system based on mini dialyzers for evaluating hemodialysis membranes under physiologically relevant conditions. ABSTRACT Background Healthy kidneys regulate acid–base balance and electrolytes, produce hormones, and clear excess fluids and uremic toxins.
M. Torrents‐Yeste, D. Ramada, O. E. M. ter Beek, F. Pel, J. de Vries, B. H. Lentferink, K. G. F. Gerritsen, D. Stamatialis   +7 more
wiley   +1 more source

Clinical Outcomes of Anticoagulation Therapy With Direct Oral Anticoagulants or Warfarin in Patients With Atrial Fibrillation and Renal Impairment After Bioprosthetic Valve Replacement. [PDF]

Circ Rep
Ito M, Takegami M, Furukawa Y, Miyake M, Fujita T, Koyama T, Tanaka H, Ando K, Komiya T, Izumo M, Kawai H, Eishi K, Yoshida K, Kimura T, Nawada R, Sakamoto T, Shibata Y, Fukui T, Minatoya K, Sakata Y, Fukuzawa M, Nishimura K, Kaneko S, Hoshiyama T, Kanazawa H, Tsujita K, Izumi C, BPV-AF Registry Group.   +27 more
europepmc   +1 more source

Percutaneous Intervention in External Outflow Graft Obstruction of Magnetically Levitated Left Ventricular Assist Device: Long‐Term Follow‐Up and Quality of Life

Artificial Organs, EarlyView.
eOGO is an uncommon adverse event in patients on long‐term LVAD support. Thirty‐one eOGO patients were identified in a single‐centre HM3 implantation program. Twenty patients underwent percutaneous stenting. This treatment resulted in immediate LVAD flow improvement and yielded satisfactory quality‐of‐life results, with 62.5% patients assigned a fair ...
Anna Huang, Julia Stein, Vanessa I. T. Zwaans, Carla L. Schuering, Gaik Nersesian, Christoph Hoermandinger, Markus Müller, Johanna Mulzer, Stephan Dreysse, Philipp Stawowy, Christoph T. Starck, Joerg Kempfert, Evgenij V. Potapov, Volkmar Falk, Leonhard Wert   +14 more
wiley   +1 more source